About ProPharma Group
ProPharma Group is a company based in Saint Paul (United States) founded in 2001 was acquired by Odyssey Investment Partners in September 2020. The company has 999 employees. ProPharma Group has completed 13 acquisitions, including Diamond Pharma Services, Diamond Pharmacy Services and Digital Lab Consulting. ProPharma Group operates in a competitive market with competitors including Validant, PharmaLex, Technical Safety Services, Celegence and Clinical Outcomes Solutions, among others.
- Headquarter Saint Paul, United States
- Employees 999
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website propharmagroup.com
- Social LinkedIn X Instagram
- Acquired by Odyssey Investment Partners (Sep 2020)
- InvestorsMonroe Capital
& 2 more
- Employee Count999
- Investments & AcquisitionsDiamond Pharma Services
& 12 more
- Acquired by
Funding Insights of ProPharma Group
- Total Rounds 2
- Investors Count 1
All 2 funding rounds of ProPharma Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | – | Debt – Conventional | β | β | |
| Aug 2018 | – | Debt – Conventional | β | β |
3 investors in total: 3 institutional.
Investors in ProPharma Group
ProPharma Group has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Monroe Capital, Linden Capital Partners and Odyssey Investment Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private debt financing is offered via specialized funds. | 2004 | monroecap.com | Chicago, United States | |
Private equity fund focused on multiple sectors | – | odysseyinvestment.com | New York, United States | |
Private equity investments are focused on the healthcare sector. | – | lindenllc.com | Chicago, United States |
Investor details for ProPharma Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ProPharma Group
52 people are tracked at ProPharma Group (33 in leadership, 19 in team); the tracked headcount is 999.
| Name | Role | Group |
|---|---|---|
Michael Stomberg | CEO | Leadership |
Mia Savino-Federico | Senior Director Business Development | Leadership |
Shane Kraft | Director, Head Of Project Finance - Clinical Research Services | Leadership |
Tom Hunter | Vice President Of Business Development | Leadership |
Gregory Kufner | Director CMC Regulatory Sciences | Leadership |
Adrian Hartley | Vice President, Business Development | Leadership |
Brittany Strubbe | Vice President, Clinical Research Solutions | Leadership |
Nikki Costantino | Vice President, Business Development Clinical Reseach Solutions (cro) | Leadership |
Laura Hopper | President, Pharmacovigilance | Leadership |
Robert Beall | Vice President | Leadership |
Brian Dwyer | Vice President, Business Development Regulatory Sciences | Leadership |
Patrick O’Hara | Senior Director Business Development | Leadership |
Suzan Omar Narducci | Vice President, R&d Technology | Leadership |
Andrea Hiser Oldham | Vice President, Quality And Compliance | Leadership |
Jamie Logan | Vice President, Business Development, Emea/apac | Leadership |
Jim Kolbet | President, Life Science Consulting | Leadership |
Rachel Bias | Chief Human Resources Officer | Leadership |
Kevin Wysocki | President, Clinical Research Solutions | Leadership |
Jason DeGoes | President, ProPharma Group | Leadership |
Kristin Ortlieb | VP, Compliance | Leadership |
32 more people are available in the full profile.
Complete people profiles for ProPharma Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ProPharma Group
ProPharma Group has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include Diamond Pharma Services, Diamond Pharmacy Services and Digital Lab Consulting.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Business consulting services for scientific informatics are provided. | dlc.io | London, United Kingdom | 2018 | Jan 2023 | β’β’β’β’ | |
Medical writing, review, and documentation services are provided. | katericonline.com | Ann Arbor, United States | 2004 | Sep 2022 | β’β’β’β’ | |
Regulatory and compliance solutions and medical review outsourcing services | onesourceregulatory.com | Libertyville, United States | 2009 | Aug 2022 | β’β’β’β’ | |
Regulatory and clinical services are provided to biopharma companies. | msquaredassociates.com | New York, United States | 2001 | Mar 2022 | β’β’β’β’ | |
Provider of clinical development & supply chain, regulatory, and consulting services for biopharma sector | pharmicaconsulting.com | Sparta, United States | 2005 | Oct 2021 | β’β’β’β’ | |
Regulatory compliance, quality processes, and safety services are provided. | isafetysystems.com | Princeton, United States | 2008 | Aug 2021 | β’β’β’β’ | |
Regulatory affairs consulting services are provided to pharmaceutical clients. | diamondpharmaservices.com | Harlow, United Kingdom | 2005 | Mar 2021 | β’β’β’β’ | |
A chain of pharmacies is operated in Indiana, United States. | diamondpharmacy.com | Indiana, United States | 1970 | Mar 2021 | β’β’β’β’ | |
Services for biopharmaceutical development, registration, and lifecycle management are offered. | southwoodresearch.com | Buckingham, United Kingdom | 2016 | Mar 2019 | β’β’β’β’ | |
Consulting services for biotech, medical devices, and pharmaceuticals are provided. | weinberggroup.com | – | 1983 | Jan 2019 | β’β’β’β’ |
Complete acquisition details for ProPharma Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ProPharma Group
15 dated milestones of ProPharma Group across 22 years, from founding to its latest funding, stage changes and deals.
- Founded ProPharma Group is founded.
- Exit Acquired by Linden Capital Partners.
- Funding First funding round.
- Acquisition Acquires Weinberg Group.
- Acquisition Acquires Southwood Research.
- Funding Latest funding round, Debt β Conventional,.
- Exit Acquired by Odyssey Investment Partners.
- Acquisition Acquires Diamond Pharmacy Services.
- Acquisition Acquires Diamond Pharma Services.
- Acquisition Acquires iSafety.
- Acquisition Acquires Pharmica.
- Acquisition Acquires M Squared Associates.
- Acquisition Acquires OneSource Regulatory.
- Acquisition Acquires Kateric.
- Acquisition Acquires Digital Lab Consulting.
Competitors of ProPharma Group
ProPharma Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Validant, PharmaLex, Technical Safety Services, Celegence and Clinical Outcomes Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| validant.com | 2005 | San Francisco, United States | $2.28M | – | Regulatory, compliance, and quality consulting for GxP lifecycles is provided. | |
| pharmalex.com | 1998 | Mannheim, Germany | – | 310 | CRO specializing in regulatory affairs and pharmacovigilance | |
| techsafety.com | 1970 | Berkeley, United States | – | 71 | Healthcare instrumentation, medical gas systems, and related devices are manufactured. | |
| celegence.com | 2017 | Downers Grove, United States | – | – | Regulatory consulting and solutions for pharmaceuticals and medical devices compliance. | |
| clinoutsolutions.com | 2013 | Tucson, United States | – | 38 | Regulatory support and consulting services are provided for clinical outcomes. | |
| mapigroup.com | 1990 | Lyon, France | $8.43M | – | Real world evidence and post-approval research services are provided. | |
| trasis.com | 2004 | Ans, Belgium | – | 218 | Provides radiopharmaceutical equipment, synthesis solutions, and custom services for labs. | |
| flyingbrands.co.uk | 1981 | Chelmsford, United Kingdom | – | – | Regulatory services are provided to the biopharma sector. | |
| pharmabioserv.com | 1993 | Dorado, Puerto Rico | $11.75M | – | Provider of regulatory compliance and validation support to life science industries |
Detailed competitors of ProPharma Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ProPharma Group
The website of ProPharma Group (propharmagroup.com) receives about 50.2K visits a month and ranks #628,956 among all websites worldwide, #683 in Biotechnology and Pharmaceuticals.
- Monthly visits50.2K
▼ 1.1% vs previous month
- Unique visitors24.2K
per month
- Global rank#628,956
among all websites
- Category rank#683
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit2.1
- Average visit46 sec
- DevicesDesktop 35% Β· Mobile 65%
Websites whose visitors overlap most with ProPharma Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| outsourcing-pharma.com | 100% | – | – | View details | |
| celegence.com | 99% | – | #1,838,577 | View details | |
| championsoncology.com | 89% | 10.5K | #2,082,227 | View details | |
| eversana.com | 88% | 38.7K | #636,017 | View details | |
medicalaffairs.org | medicalaffairs.org | 88% | – | #1,152,217 | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for ProPharma Group
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Propharma Group
Complete news archive for ProPharma Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ProPharma Group
10 companies that operate in the same segment as ProPharma Group (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ProPharma Group
ProPharma Group was founded in 2001 and raised its 1st funding round 17 years after it was founded.
ProPharma Group is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Michael Stomberg is the current CEO of ProPharma Group.
ProPharma Group has 999 employees.
ProPharma Group was established in 2001 and is based in Saint Paul, United States. Regulatory compliance solutions are delivered by the company to support pharmaceutical, biotechnology, and medical device industries. Services encompass guidance on regulatory standards, documentation, and auditing processes to facilitate market access and ongoing compliance. Operations are centered in the life sciences sector, with a focus on North American markets, under the leadership of CEO Michael Stomberg.
ProPharma Group's top competitors include PharmaLex, Pharma-Bio Serv and Validant.
ProPharma Group has made 13 acquisitions, including Diamond Pharma Services, Diamond Pharmacy Services, and Digital Lab Consulting.
ProPharma Group has 3 investors. Key investors include Monroe Capital, Linden Capital Partners, and Odyssey Investment Partners.
Yes. ProPharma Group was acquired by Odyssey Investment Partners in September 2020.

